Journal
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume 175, Issue 2, Pages 305-315Publisher
WILEY
DOI: 10.1111/cei.12232
Keywords
coeliac disease; diagnostics; gluten challenge
Categories
Funding
- Mexican Council for Science and Technology (CONACyT)
- NHMRC [406656]
- Walter and Eliza Hall Institute and Melbourne Health
- Coeliac Australia
- NHMRC Independent Research Institutes Infrastructure Support Scheme [361646]
- Victorian State Government
Ask authors/readers for more resources
T cell cytokine release assays are used to diagnose infectious diseases, but not autoimmune or allergic disease. Coeliac disease (CD) is a common T cell-mediated disease diagnosed by the presence of gluten-dependent intestinal inflammation and serology. Many patients cannot be diagnosed with CD because they reduce dietary gluten before medical workup. Oral gluten challenge in CD patients treated with gluten-free diet (GFD) mobilizes gluten-reactive T cells measurable by interferon (IFN)-gamma enzyme-linked immunospot (ELISPOT) or major histocompatibility complex (MHC) class II tetramers. Immunodominant peptides are quite consistent in the 90% of patients who possess HLA-DQ2.5. We aimed to develop whole blood assays to detect gluten-specific T cells. Blood was collected before and after gluten challenge from GFD donors confirmed to have CD (n=27, all HLA-DQ25(+)), GFD donors confirmed not to have CD (n=6 HLA-DQ2.5(+), 11 HLA-DQ2.5(-)) and donors with CD not following GFD (n=4, all HLA-DQ2.5(+)). Plasma IFN-gamma and IFN-gamma inducible protein-10 (IP-10) were measured by enzyme-linked immunosorbent assay (ELISA) after whole blood incubation with peptides or gliadin, and correlated with IFN-gamma ELISPOT. No T cell assay could distinguish between CD patients and controls prior to gluten challenge, but after gluten challenge the whole blood IFN-gamma ELISA and the ELISPOT were both 85% sensitive and 100% specific for HLA-DQ2.5(+) CD patients; the whole blood IP-10 ELISA was 94% sensitive and 100% specific. We conclude that whole blood cytokine release assays are sensitive and specific for detection of gluten-reactive T cells in CD; further clinical studies addressing the utility of these tests in patients with an uncertain diagnosis of CD is warranted.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available